Mandate

Vinge advises Eleda’s shareholders in connection with partnership with Altor

Vinge has advised the shareholders of Eleda Infra Services Group (“Eleda”) on the divestment of a majority stake in Eleda to Altor Fund V.

As part of the transaction, Eleda acquires and partners with the entrepreneurs of Järfälla VA- & Byggentreprenad AB and divests KEWAB, Kenneth Wahlström Aktiebolag. In addition, Eleda acquires ONE Nordic from Altor Fund III. Management of the respective companies will remain as significant shareholders of the combined group and continue in their respective operational management roles.

The new, larger, Eleda will be an expansive infrastructure services group focusing on small to medium sized civil engineering and transmission infrastructure projects and services across a wide range of sectors including water works, road works, energy works and data centers.  The companies have an impressive history of strong growth and a proven ability to gain additional market shares in fast-growing areas of the market. The new Eleda group had a combined turnover of ca SEK 6 billion in 2019.

The transaction is subject to customary regulatory approvals.

Vinge’s team consisted of partner Christina Kokko together with associates Manne Bergström, Michaela Cronemyr, Johanna Wiberg, Fredric Reissmüller, Hanna Risberg, Stina Bengtsson and Jonathan Riddersholm (M&A), Trine Osen Bergqvist, Xandra Ståhlberg and Lisa Malmborg (Competition), Josefine Lanker (Banking and Finance), Jessica Öijer and Christoffer Widström (VDR Specialists) and Nathalie Hughes (VDR Assistant).

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025